Cost-effectiveness of botulinum neurotoxin A versus surgery for drooling: a randomized clinical trial.
Stijn BekkersKim J van UlsenEddy M M AdangArthur R T SchefferFrank J A van den HoogenPublished in: Developmental medicine and child neurology (2020)
Botulinum neurotoxin A (BoNT-A) is less expensive per percentage of success than two-duct ligation. The additional cost of two-duct ligation over BoNT-A is offset by greater treatment success.